New preclinical research from the Perelman School of Medicine at the University of Pennsylvania suggests that an innovative vaccine candidate can prevent developing Lyme disease in people.
While there are existing Lyme disease vaccines for dogs, no vaccine candidate is approved for people.
Lyme Disease Vaccine Candidate Leverages mRNA Technology
Strategic Plan for Herpes Research Includes Vaccines
To advance the clinical research into herpes simplex virus (HSV) infections, the U.S. National Institutes of Health (NIH) today released the Strategic Plan for HSV.
An NIH-wide HSV Working Group was formed in October 2022 to develop this plan, informed by feedback from more than 100 representatives of the research and advocacy communities and stakeholders.